Robin Jones to Immunotherapy
This is a "connection" page, showing publications Robin Jones has written about Immunotherapy.
Connection Strength
0.799
-
The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncol. 2018 May; 14(12):1197-1211.
Score: 0.595
-
Future Directions in the Treatment of Osteosarcoma. Cells. 2021 01 15; 10(1).
Score: 0.180
-
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. PLoS One. 2012; 7(2):e32165.
Score: 0.024